149 related articles for article (PubMed ID: 21209173)
1. Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.
Shak JR; Whitaker JA; Ribner BS; Burd EM
J Clin Microbiol; 2011 Mar; 49(3):1169-70. PubMed ID: 21209173
[TBL] [Abstract][Full Text] [Related]
2. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.
Ko WC; Yu KW; Liu CY; Huang CT; Leu HS; Chuang YC
Antimicrob Agents Chemother; 1996 May; 40(5):1260-2. PubMed ID: 8723478
[TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone-Resistant Aeromonas hydrophila Infection Following Leech Therapy: A New Resistant Strain.
Bykowski MR; Zhu X; Diaz-Garcia R
Ann Plast Surg; 2018 Sep; 81(3):327-328. PubMed ID: 29944526
[TBL] [Abstract][Full Text] [Related]
4. Emerging extra-intestinal infections with Aeromonas hydrophila in coastal region of southern Karnataka.
Mukhopadhyay C; Chawla K; Sharma Y; Bairy I
J Postgrad Med; 2008; 54(3):199-202. PubMed ID: 18626167
[TBL] [Abstract][Full Text] [Related]
5. Aspects of constitutive and acquired antibioresistance in Aeromonas hydrophila strains isolated from water sources.
Balotescu C; Israil A; Radu R; Alexandru I; Dobre G
Roum Arch Microbiol Immunol; 2003; 62(3-4):179-89. PubMed ID: 16008142
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of aminoglycoside resistance. European data.
Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
[TBL] [Abstract][Full Text] [Related]
7. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
Murray BE; Moellering RC
Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
[TBL] [Abstract][Full Text] [Related]
8. Proteomic characterization and discrimination of Aeromonas species recovered from meat and water samples with a spotlight on the antimicrobial resistance of Aeromonas hydrophila.
Elbehiry A; Marzouk E; Abdeen E; Al-Dubaib M; Alsayeqh A; Ibrahem M; Hamada M; Alenzi A; Moussa I; Hemeg HA
Microbiologyopen; 2019 Nov; 8(11):e782. PubMed ID: 30614207
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
Brewer NS
Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.
Anderson SE; Sherman EX; Weiss DS; Rather PN
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111627
[TBL] [Abstract][Full Text] [Related]
11. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
12. [In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
Anan N; Toba S; Ito A; Nakamura R; Tsuji M
Jpn J Antibiot; 2011 Aug; 64(4):203-16. PubMed ID: 22066345
[TBL] [Abstract][Full Text] [Related]
13. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
14. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Murray PR
Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
[TBL] [Abstract][Full Text] [Related]
15. Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins.
Appleby DH; John JF
Nephron; 1982; 30(4):341-4. PubMed ID: 7110465
[TBL] [Abstract][Full Text] [Related]
16. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
Kelly MT; Matsen JM
Antimicrob Agents Chemother; 1976 Mar; 9(3):440-7. PubMed ID: 1259402
[TBL] [Abstract][Full Text] [Related]
18. [Extraintestinal infection due to Aeromonas spp.: review of 38 cases].
Tena D; González-Praetorius A; Gimeno C; Pérez-Pomata MT; Bisquert J
Enferm Infecc Microbiol Clin; 2007 Apr; 25(4):235-41. PubMed ID: 17386217
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside resistance: a worldwide perspective.
Young LS; Hindler J
Am J Med; 1986 Jun; 80(6B):15-21. PubMed ID: 3089000
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
